Logo image of TLYS

TILLY'S INC-CLASS A SHRS (TLYS) Stock Fundamental Analysis

NYSE:TLYS - New York Stock Exchange, Inc. - US8868851028 - Common Stock - Currency: USD

3.65  -0.09 (-2.41%)

After market: 3.65 0 (0%)

Fundamental Rating

2

Overall TLYS gets a fundamental rating of 2 out of 10. We evaluated TLYS against 120 industry peers in the Specialty Retail industry. While TLYS seems to be doing ok healthwise, there are quite some concerns on its profitability. TLYS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TLYS had negative earnings in the past year.
TLYS had a negative operating cash flow in the past year.
In multiple years TLYS reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: TLYS reported negative operating cash flow in multiple years.
TLYS Yearly Net Income VS EBIT VS OCF VS FCFTLYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

TLYS's Return On Assets of -13.72% is on the low side compared to the rest of the industry. TLYS is outperformed by 78.63% of its industry peers.
TLYS has a worse Return On Equity (-46.47%) than 70.94% of its industry peers.
Industry RankSector Rank
ROA -13.72%
ROE -46.47%
ROIC N/A
ROA(3y)2.24%
ROA(5y)2.13%
ROE(3y)6.14%
ROE(5y)6.37%
ROIC(3y)N/A
ROIC(5y)N/A
TLYS Yearly ROA, ROE, ROICTLYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

TLYS has a Gross Margin of 26.57%. This is in the lower half of the industry: TLYS underperforms 74.36% of its industry peers.
In the last couple of years the Gross Margin of TLYS has declined.
The Profit Margin and Operating Margin are not available for TLYS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.22%
GM growth 5Y-2.53%
TLYS Yearly Profit, Operating, Gross MarginsTLYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

TLYS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TLYS has been increased compared to 1 year ago.
Compared to 5 years ago, TLYS has more shares outstanding
TLYS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TLYS Yearly Shares OutstandingTLYS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
TLYS Yearly Total Debt VS Total AssetsTLYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 1.36, we must say that TLYS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.36, TLYS is doing worse than 72.65% of the companies in the same industry.
TLYS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.36
ROIC/WACCN/A
WACC10.27%
TLYS Yearly LT Debt VS Equity VS FCFTLYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

TLYS has a Current Ratio of 1.35. This is a normal value and indicates that TLYS is financially healthy and should not expect problems in meeting its short term obligations.
TLYS has a Current ratio of 1.35. This is comparable to the rest of the industry: TLYS outperforms 46.15% of its industry peers.
TLYS has a Quick Ratio of 1.35. This is a bad value and indicates that TLYS is not financially healthy enough and could expect problems in meeting its short term obligations.
TLYS has a better Quick ratio (0.58) than 60.68% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.58
TLYS Yearly Current Assets VS Current LiabilitesTLYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

TLYS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -237.30%.
TLYS shows a decrease in Revenue. In the last year, the revenue decreased by -5.60%.
The Revenue has been growing slightly by 0.81% on average over the past years.
EPS 1Y (TTM)-237.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1326.67%
Revenue 1Y (TTM)-5.6%
Revenue growth 3Y5.46%
Revenue growth 5Y0.81%
Sales Q2Q%-13.84%

3.2 Future

The Earnings Per Share is expected to grow by 24.65% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 0.99% on average over the next years.
EPS Next Y-115.95%
EPS Next 2Y-1.78%
EPS Next 3Y13.6%
EPS Next 5Y24.65%
Revenue Next Year-6.59%
Revenue Next 2Y-2.76%
Revenue Next 3Y-0.1%
Revenue Next 5Y0.99%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TLYS Yearly Revenue VS EstimatesTLYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
TLYS Yearly EPS VS EstimatesTLYS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TLYS. In the last year negative earnings were reported.
Also next year TLYS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLYS Price Earnings VS Forward Price EarningsTLYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TLYS Per share dataTLYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

TLYS's earnings are expected to grow with 13.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.78%
EPS Next 3Y13.6%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TLYS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TILLY'S INC-CLASS A SHRS

NYSE:TLYS (2/21/2025, 8:04:00 PM)

After market: 3.65 0 (0%)

3.65

-0.09 (-2.41%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-05 2024-12-05/amc
Earnings (Next)06-04 2025-06-04/amc
Inst Owners100.04%
Inst Owner Change-0.16%
Ins Owners1.96%
Ins Owner Change0%
Market Cap110.05M
Analysts45.71
Price Target5.1 (39.73%)
Short Float %3.65%
Short Ratio7.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)43.3%
Min EPS beat(2)-13.41%
Max EPS beat(2)100%
EPS beat(4)2
Avg EPS beat(4)18.32%
Min EPS beat(4)-37.54%
Max EPS beat(4)100%
EPS beat(8)5
Avg EPS beat(8)81.56%
EPS beat(12)7
Avg EPS beat(12)64.16%
EPS beat(16)11
Avg EPS beat(16)191.59%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.52%
Max Revenue beat(2)-0.14%
Revenue beat(4)0
Avg Revenue beat(4)-1.39%
Min Revenue beat(4)-2.52%
Max Revenue beat(4)-0.14%
Revenue beat(8)1
Avg Revenue beat(8)-1.06%
Revenue beat(12)2
Avg Revenue beat(12)-0.99%
Revenue beat(16)5
Avg Revenue beat(16)1.37%
PT rev (1m)0%
PT rev (3m)-16.67%
EPS NQ rev (1m)-321.43%
EPS NQ rev (3m)-168.18%
EPS NY rev (1m)0%
EPS NY rev (3m)-23.18%
Revenue NQ rev (1m)-6.45%
Revenue NQ rev (3m)-6.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 0.96
EV/EBITDA N/A
EPS(TTM)-1.25
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)-1.48
FCFYN/A
OCF(TTM)-1.14
OCFYN/A
SpS19.74
BVpS3.79
TBVpS3.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.72%
ROE -46.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.57%
FCFM N/A
ROA(3y)2.24%
ROA(5y)2.13%
ROE(3y)6.14%
ROE(5y)6.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.22%
GM growth 5Y-2.53%
F-Score3
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 78.4%
Cap/Sales 1.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 0.58
Altman-Z 1.36
F-Score3
WACC10.27%
ROIC/WACCN/A
Cap/Depr(3y)98.51%
Cap/Depr(5y)81.64%
Cap/Sales(3y)2.07%
Cap/Sales(5y)2.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-237.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1326.67%
EPS Next Y-115.95%
EPS Next 2Y-1.78%
EPS Next 3Y13.6%
EPS Next 5Y24.65%
Revenue 1Y (TTM)-5.6%
Revenue growth 3Y5.46%
Revenue growth 5Y0.81%
Sales Q2Q%-13.84%
Revenue Next Year-6.59%
Revenue Next 2Y-2.76%
Revenue Next 3Y-0.1%
Revenue Next 5Y0.99%
EBIT growth 1Y-86.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2.38%
EBIT Next 3Y23.05%
EBIT Next 5Y27.71%
FCF growth 1Y-398%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-730.31%
OCF growth 3YN/A
OCF growth 5YN/A